Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Income towards Parent Company (2022 - 2025)

Moolec Science (MLECW) posted Income towards Parent Company of $153317.0 for Q4 2025, down 74.25% sequentially from $595351.0 in Q4 2024, and down 74.25% YoY from $595351.0 in Q4 2024.

Moolec Science (MLECW) Income towards Parent Company (2022 - 2025) Analysis & Trends

Moolec Science has reported Income towards Parent Company for 4 years, with the latest figure at $153317.0 in Q4 2025.

  • Quarterly Income towards Parent Company fell 74.25% year-over-year to $153317.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$3.1 million (changed N/A YoY) and the FY2024 annual result came in at -$32.9 million, down 181.3% from the prior year.
  • Income towards Parent Company eased to $153317.0 in Q4 2025 per MLECW's latest filing, from $595351.0 in the prior quarter.
  • Over five years, Income towards Parent Company peaked at $48.0 million in Q4 2022 and troughed at -$15.7 million in Q2 2023.
  • A 4-year average of $3.1 million and a median of -$721426.0 in 2022 frame the typical range for Income towards Parent Company.
  • The widest YoY moves for Income towards Parent Company: up 69.28% in 2023, down 232.1% in 2023.
  • Over 4 years, Income towards Parent Company stood at $48.0 million in 2022, then tumbled by 83.15% to $8.1 million in 2023, then sank by 92.63% to $595351.0 in 2024, then plunged by 74.25% to $153317.0 in 2025.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered $153317.0, $595351.0, and -$2.0 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Moolec Science 8,617.72 -1.19 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 153,317.00
Dec 31, 2024 595,351.00
Sep 30, 2024 -1.97 Mn
Jun 30, 2024 -5.45 Mn
Mar 31, 2024 -1.15 Mn
Dec 31, 2023 8.08 Mn
Sep 30, 2023 -1.81 Mn
Jun 30, 2023 -15.67 Mn
Mar 31, 2023 -358,578.00
Dec 31, 2022 47.96 Mn
Sep 30, 2022 -721,426.00
Jun 30, 2022 11.86 Mn
Mar 31, 2022 -1.17 Mn